Yapay Zeka Hızlı Bakış & Çıkarımlar
AI InsightConclusion: EVLA for symptomatic saphenous vein incompetence is a minimally invasive and successful technique in resolving varicose veins and reducing symptoms.
📌 3 Maddede Bu Makale
Özet
To present the long-term results of our 158 endovenous laser ablation (EVLA) procedures. Materials and methods: From June 2008 to December 2011, 158 patients (89 women, 69 men; mean age: 38.2 years, range: 27-65) were treated with EVLA for venous insufficiency in 192 lower limbs. All patients were symptomatic and the majority had a class 4 or higher clinical disease (CEAP classification). A 980-nm diode laser was used under general anesthesia combined with local tumescent anesthesia to deliver 100 to 140 laser applications along the course of the vein. Compression bandages were applied for 2 weeks postoperatively. Follow-up exams were done by Doppler ultrasound exam at 4 weeks, 6 months, 1 year, and 2 years. Results: A total of 192 great saphenous veins were ablated, achieving a 99% clinical success rate. Postoperative complications were mild and well tolerated. Of the 2 (1.0%) recanalized target veins, 2 were successfully treated with a second EVLA procedure. After 3 to 6 months of EVLA treatment, 99% of the patients had significant relief of their symptoms. All patients returned to normal activity within 2 days. Conclusion: EVLA for symptomatic saphenous vein incompetence is a minimally invasive and successful technique in resolving varicose veins and reducing symptoms.
Abstract
To present the long-term results of our 158 endovenous laser ablation (EVLA) procedures. Materials and methods: From June 2008 to December 2011, 158 patients (89 women, 69 men; mean age: 38.2 years, range: 27-65) were treated with EVLA for venous insufficiency in 192 lower limbs. All patients were symptomatic and the majority had a class 4 or higher clinical disease (CEAP classification). A 980-nm diode laser was used under general anesthesia combined with local tumescent anesthesia to deliver 100 to 140 laser applications along the course of the vein. Compression bandages were applied for 2 weeks postoperatively. Follow-up exams were done by Doppler ultrasound exam at 4 weeks, 6 months, 1 year, and 2 years. Results: A total of 192 great saphenous veins were ablated, achieving a 99% clinical success rate. Postoperative complications were mild and well tolerated. Of the 2 (1.0%) recanalized target veins, 2 were successfully treated with a second EVLA procedure. After 3 to 6 months of EVLA treatment, 99% of the patients had significant relief of their symptoms. All patients returned to normal activity within 2 days. Conclusion: EVLA for symptomatic saphenous vein incompetence is a minimally invasive and successful technique in resolving varicose veins and reducing symptoms.